Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1139 Results

Title
Intervention Indication Therapeutic Area Year Actions
Encorafenib in combination with binimetinib and cetuximab for BRAF V600E mutant metastatic colorectal cancer Binimetinib (MEK162; MEK-162; ARRY-162) , Cetuximab (Erbitux; STI-001) , Encorafenib (LGX818) Colorectal cancer Gastrointestinal Cancer , Oncology 2019 View  |  Download
Enasidenib for Relapsed or Refractory Acute Myeloid Leukaemia (AML) with an Isocitrate Dehydrogenase 2 (IDH2) Mutation Enasidenib (Idhifa; AG-221; CC-90007) Acute myeloid leukaemia (AML) Haematological Cancer and Lymphomas 2018 View  |  Download
Empagliflozin with linagliptin for treating type 2 diabetes mellitus in children and adolescents Empagliflozin (Jardiance; DINAMO) , Linagliptin Type 2 diabetes Endocrine Nutritional and Metabolic Disorders 2022 View  |  Download
Empagliflozin for treatment of chronic heart failure with reduced ejection fraction Empagliflozin (Jardiance; DINAMO) Heart failure (HF) Cardiovascular System 2020 View  |  Download
Empagliflozin for treating chronic kidney disease Empagliflozin (Jardiance; DINAMO) Chronic kidney disease (CKD) Cardiovascular System , Nephrology 2022 View  |  Download
Empagliflozin for the treatment of acute myocardial infarction to reduce heart failure and mortality Empagliflozin (Jardiance; DINAMO) Heart failure (HF) Cardiovascular System 2022 View  |  Download
Empagliflozin for Chronic Heart Failure with Preserved Ejection Fraction Empagliflozin (Jardiance; DINAMO) Heart failure (HF) Cardiovascular System 2021 View  |  Download
Emicizumab for mild or moderate haemophilia A Emicizumab (Hemlibra) Haemophilia A Haematology 2021 View  |  Download
Emapalumab for Primary Haemophagocytic Lymphohistiocytosis Emapalumab (NI-0501; Gamifant) Primary haemophagocytic lymphohistiocytosis (HLH) Genetic Disorders , Immunology 2018 View  |  Download
Elranatamab monotherapy or with daratumumab for previously treated relapsed or refractory multiple myeloma Daratumumab (Darzalex; JNJ-54767414) , Elranatamab (PF-06863135) Multiple myeloma (MM) Haematological Cancer and Lymphomas , Skin Cancer 2024 View  |  Download
1 2 76 77 78 79 80 113 114
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications